Interestingly, while TET genes are frequently downregulated in tumors, a recent study reported that TET1 is upregulated in MLL-rearranged leukemia which is accompanied by a global increase in 5hmC levels, suggesting a role for TET1 as an oncogene instead of a tumor suppressor. The gene discussed is TET1; the disease is neoplasm.